Tag: PSMA-PET
-
PSMA-PET/CT May Replace NaF-PET/CT in Advanced Prostate Cancer Staging
Study Overview: Assessing the shift from NaF-PET/CT to PSMA-PET/CT Researchers in Denmark explored whether replacing F-18 sodium fluoride (NaF) PET/CT imaging with F-18 PSMA-PET/CT would influence treatment decisions for men with newly diagnosed, high-risk prostate cancer. The study involved 160 patients who underwent both imaging modalities within a three-week window. Initially, treatment decisions were based…
-
PSMA-PET/CT Could Replace NaF-PET/CT in Advanced Prostate Cancer
New Evidence Supports a Shift in Prostate Cancer Imaging Researchers in Denmark have found that replacing F-18 sodium fluoride (NaF) PET/CT with F-18 prostate-specific membrane antigen (PSMA) PET/CT could meaningfully influence treatment decisions for men with newly diagnosed high-risk prostate cancer. In a prospective, within-patient comparison, the study suggests that PSMA-PET/CT not only improves diagnostic…